draflazine has been researched along with Coronary Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janssen, PA; Robertson, JI; Van Belle, H; Ver Donck, K; Verheyen, W | 1 |
| Aksnes, G; Ilebekk, A; Kirkebøen, KA; Lande, K | 1 |
2 other study(ies) available for draflazine and Coronary Disease
| Article | Year |
|---|---|
Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor.
Topics: Animals; Blood Glucose; Coronary Disease; Epinephrine; Female; Heart; Isoenzymes; L-Lactate Dehydrogenase; Male; Myocardial Infarction; Norepinephrine; Nucleosides; Piperazines; Rabbits; Ventricular Function, Left | 1992 |
Role of adenosine for reactive hyperemia in normal and stunned porcine myocardium.
Topics: Adenosine; Adenosine Deaminase; Animals; Coronary Disease; Female; Hemodynamics; Hyperemia; Male; Myocardial Reperfusion Injury; Piperazines; Reference Values; Swine | 1992 |